Cargando…
Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502657/ https://www.ncbi.nlm.nih.gov/pubmed/32830858 http://dx.doi.org/10.1042/BSR20201519 |
_version_ | 1783584245855289344 |
---|---|
author | You, Qian Peng, Qing Yu, Zemou Jin, Haiqiang Zhang, Jing Sun, Wei Huang, Yining |
author_facet | You, Qian Peng, Qing Yu, Zemou Jin, Haiqiang Zhang, Jing Sun, Wei Huang, Yining |
author_sort | You, Qian |
collection | PubMed |
description | Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes. Methods: 20 patients with LAA cerebrovascular disease, 20 patients with age-related CSVD, 10 patients with Fabry disease and 14 controls were enrolled from October 2017 to January 2019. Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectrometry/mass spectrometry was used to determine sphingolipids. Univariate combined with multivariate analysis was used for comparison. Receiver operating characteristic curves were used to determine sensitivities and specificities. Results: 276 sphingolipids were detected, including 39 Cer, 3 ceramide phosphates, 72 glycosphingolipids and 162 SM. (1) Cer (d36:3), Cer (d34:2), Cer (d38:6), Cer (d36:4) and Cer (d16:0/18:1) were increased in LAA; SM (d34:1), Cer (d34:2), Cer (d36:4), Cer (d16:0/18:1), Cer (d38:6), Cer (d36:3) and Cer (d32:0) were increased in age-related CSVD. (2) Cer (d36:4) and SM (d34:1) were increased in age-related CSVD compared with LAA. (3) Total trihexosyl ceramides were increased in Fabry group compared with control (P<0.05); SM (d34:1) was increased in Fabry group. Conclusions: Ceramides are increased in both LAA and age-related CSVD, which may be related to similar risk factors and pathophysiological process of arteriosclerosis; SM is increased in both age-related CSVD and Fabry disease, suggesting that increased SM may be associated with CSVD. Glycosphingolipids, trihexosylceramides in particular, are increased in Fabry disease. |
format | Online Article Text |
id | pubmed-7502657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75026572020-09-28 Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease You, Qian Peng, Qing Yu, Zemou Jin, Haiqiang Zhang, Jing Sun, Wei Huang, Yining Biosci Rep Diagnostics & Biomarkers Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes. Methods: 20 patients with LAA cerebrovascular disease, 20 patients with age-related CSVD, 10 patients with Fabry disease and 14 controls were enrolled from October 2017 to January 2019. Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectrometry/mass spectrometry was used to determine sphingolipids. Univariate combined with multivariate analysis was used for comparison. Receiver operating characteristic curves were used to determine sensitivities and specificities. Results: 276 sphingolipids were detected, including 39 Cer, 3 ceramide phosphates, 72 glycosphingolipids and 162 SM. (1) Cer (d36:3), Cer (d34:2), Cer (d38:6), Cer (d36:4) and Cer (d16:0/18:1) were increased in LAA; SM (d34:1), Cer (d34:2), Cer (d36:4), Cer (d16:0/18:1), Cer (d38:6), Cer (d36:3) and Cer (d32:0) were increased in age-related CSVD. (2) Cer (d36:4) and SM (d34:1) were increased in age-related CSVD compared with LAA. (3) Total trihexosyl ceramides were increased in Fabry group compared with control (P<0.05); SM (d34:1) was increased in Fabry group. Conclusions: Ceramides are increased in both LAA and age-related CSVD, which may be related to similar risk factors and pathophysiological process of arteriosclerosis; SM is increased in both age-related CSVD and Fabry disease, suggesting that increased SM may be associated with CSVD. Glycosphingolipids, trihexosylceramides in particular, are increased in Fabry disease. Portland Press Ltd. 2020-09-18 /pmc/articles/PMC7502657/ /pubmed/32830858 http://dx.doi.org/10.1042/BSR20201519 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). |
spellingShingle | Diagnostics & Biomarkers You, Qian Peng, Qing Yu, Zemou Jin, Haiqiang Zhang, Jing Sun, Wei Huang, Yining Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title | Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title_full | Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title_fullStr | Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title_full_unstemmed | Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title_short | Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
title_sort | plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease |
topic | Diagnostics & Biomarkers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502657/ https://www.ncbi.nlm.nih.gov/pubmed/32830858 http://dx.doi.org/10.1042/BSR20201519 |
work_keys_str_mv | AT youqian plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT pengqing plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT yuzemou plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT jinhaiqiang plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT zhangjing plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT sunwei plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease AT huangyining plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease |